BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35194343)

  • 1. Financing Constraints and Firm's Productivity Under the COVID-19 Epidemic Shock: Evidence of A-Shared Chinese Companies.
    Wong Z; Chen A; Taghizadeh-Hesary F; Li R; Kong Q
    Eur J Dev Res; 2023; 35(1):167-195. PubMed ID: 35194343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discretionary Effort on Green Technology Innovation: How Chinese Enterprises Act when Facing Financing Constraints.
    Zhang K; Liu X; Hong M
    PLoS One; 2021; 16(12):e0261589. PubMed ID: 34936690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of smart city pilots on corporate total factor productivity.
    Chen P
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):83155-83168. PubMed ID: 35763146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental regulation, firms' bargaining power, and firms' total factor productivity: evidence from China.
    Yang S; Wang C; Zhang H; Lu T; Yi Y
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):9341-9353. PubMed ID: 34499302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of energy consumption structure transformation on firms' total factor productivity: evidence from China.
    Zhang Z; Ma Y
    Environ Sci Pollut Res Int; 2023 Jul; 30(31):76950-76968. PubMed ID: 37249767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How R&D intensive firms react to the COVID-19 pandemic: Evidence from a quasi-natural experiment.
    Pham THL; Nguyen DHT; Chu VT; Nguyen KD; Pham BT
    Heliyon; 2023 Sep; 9(9):e19329. PubMed ID: 37662736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sadder but Wiser: The Role of SARS Imprinting and Firms' Recovery During the COVID-19 Pandemic.
    Yao H; Wang J; Bo Q; Li M
    Front Psychol; 2022; 13():917337. PubMed ID: 35756304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corporate financialization, financing constraints, and innovation efficiency-Empirical evidence based on listed Chinese pharmaceutical companies.
    Zhu J; Tang Y; Wei Y; Wang S; Chen Y
    Front Public Health; 2023; 11():1085148. PubMed ID: 37124778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital finance and Chinese corporate labor investment efficiency: The perspective of financing constraints and human capital structure.
    Yang J; Jiang Y; Chen H; Gan S
    Front Psychol; 2022; 13():962806. PubMed ID: 36033042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dialect diversity and total factor productivity: Evidence from Chinese listed companies.
    Xiong J; Chen L
    Front Psychol; 2022; 13():1017397. PubMed ID: 36438310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can the low-carbon city pilot policy promote firms' low-carbon innovation: Evidence from China.
    Yang G
    PLoS One; 2023; 18(1):e0277879. PubMed ID: 36630425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of market-incentive environmental regulation on the development of the new energy vehicle industry: a quasi-natural experiment based on China's dual-credit policy.
    Dong F; Zheng L
    Environ Sci Pollut Res Int; 2022 Jan; 29(4):5863-5880. PubMed ID: 34426867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of different government subsidies on total-factor productivity: Evidence from private listed manufacturing enterprises in China.
    Wang D; Sun Y
    PLoS One; 2022; 17(1):e0263018. PubMed ID: 35100316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental Information Disclosure, Digital Transformation, and Total Factor Productivity: Evidence from Chinese Heavy Polluting Listed Companies.
    Liu H; Liu W; Chen G
    Int J Environ Res Public Health; 2022 Aug; 19(15):. PubMed ID: 35955011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Signing Auditor's Reputational Promotion Ease the Financing Constraints of Audited Firms?
    Gu C; Zhao R
    Comput Intell Neurosci; 2022; 2022():3286181. PubMed ID: 35965769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can green credit increase firm value? Evidence from Chinese listed new energy companies.
    Lai X; Yue S; Chen H
    Environ Sci Pollut Res Int; 2022 Mar; 29(13):18702-18720. PubMed ID: 34697707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Firm productivity gains in a period of slow trade liberalization: evidence from Brazil.
    Cirera X; Lederman D; Máñez Castillejo JA; Rochina Barrachina ME; Sanchis-Llopis JA
    Econ Polit (Bologna); 2021; 38(1):57-87. PubMed ID: 35422581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reacting to the economic fallout of the COVID-19: Evidence on debt exposure and asset management of Italian firms.
    Ferragina AM; Iandolo S
    Econ Anal Policy; 2022 Sep; 75():530-547. PubMed ID: 35754528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.